Cesar Boggiano

Sep 4, 2024 | science.org | Anjali Singh |Xue Zhang |Zhuo Chen |Cesar Boggiano

AbstractElucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in pediatric vaccine design. A better understanding of age-specific adjuvants will inform precision discovery and development of safe and effective vaccines for protecting children from preventable infectious diseases. Get full access to this articleView all available purchase options and get full access to this article.